OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Orexin and Parkinson's disease: A protective neuropeptide with therapeutic potential
Cui Liu, Yan Xue, Meifang Liu, et al.
Neurochemistry International (2020) Vol. 138, pp. 104754-104754
Closed Access | Times Cited: 25
Cui Liu, Yan Xue, Meifang Liu, et al.
Neurochemistry International (2020) Vol. 138, pp. 104754-104754
Closed Access | Times Cited: 25
Showing 25 citing articles:
Hypoxia signaling in human health and diseases: implications and prospects for therapeutics
Zhen Luo, Mingfu Tian, Ge Yang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 233
Zhen Luo, Mingfu Tian, Ge Yang, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 233
Hypoxia-Inducible Factor (HIF) in Ischemic Stroke and Neurodegenerative Disease
Еlena V. Mitroshina, Maria O. Savyuk, Evgeni Ponimaskin, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 81
Еlena V. Mitroshina, Maria O. Savyuk, Evgeni Ponimaskin, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 81
Targeting Orexin Receptors for the Treatment of Insomnia: From Physiological Mechanisms to Current Clinical Evidence and Recommendations
Maria P. Mogavero, Alessandro Silvani, Giuseppe Lanza, et al.
Nature and Science of Sleep (2023) Vol. Volume 15, pp. 17-38
Open Access | Times Cited: 23
Maria P. Mogavero, Alessandro Silvani, Giuseppe Lanza, et al.
Nature and Science of Sleep (2023) Vol. Volume 15, pp. 17-38
Open Access | Times Cited: 23
Orexin pathway in Parkinson’s disease: a review
Mohammed Alrouji, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 7, pp. 6107-6120
Closed Access | Times Cited: 23
Mohammed Alrouji, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Molecular Biology Reports (2023) Vol. 50, Iss. 7, pp. 6107-6120
Closed Access | Times Cited: 23
The Spectrum of Sleep Disorders in Parkinson Disease
Annie C. Lajoie, Anne‐Louise Lafontaine, Marta Kamińska
CHEST Journal (2020) Vol. 159, Iss. 2, pp. 818-827
Closed Access | Times Cited: 53
Annie C. Lajoie, Anne‐Louise Lafontaine, Marta Kamińska
CHEST Journal (2020) Vol. 159, Iss. 2, pp. 818-827
Closed Access | Times Cited: 53
Biosensors in Parkinson’s disease
Ahmad Mobed, Siamak Razavi, Ali Ahmadalipour, et al.
Clinica Chimica Acta (2021) Vol. 518, pp. 51-58
Closed Access | Times Cited: 42
Ahmad Mobed, Siamak Razavi, Ali Ahmadalipour, et al.
Clinica Chimica Acta (2021) Vol. 518, pp. 51-58
Closed Access | Times Cited: 42
NADPH and Mitochondrial Quality Control as Targets for a Circadian-Based Fasting and Exercise Therapy for the Treatment of Parkinson’s Disease
William M. Curtis, William A. Seeds, Mark P. Mattson, et al.
Cells (2022) Vol. 11, Iss. 15, pp. 2416-2416
Open Access | Times Cited: 36
William M. Curtis, William A. Seeds, Mark P. Mattson, et al.
Cells (2022) Vol. 11, Iss. 15, pp. 2416-2416
Open Access | Times Cited: 36
Pharmacological Management of Apathy in Dementia
Laiba Azhar, Raphael W. Kusumo, Giovanni Marotta, et al.
CNS Drugs (2022) Vol. 36, Iss. 2, pp. 143-165
Closed Access | Times Cited: 25
Laiba Azhar, Raphael W. Kusumo, Giovanni Marotta, et al.
CNS Drugs (2022) Vol. 36, Iss. 2, pp. 143-165
Closed Access | Times Cited: 25
Cardiovascular Dysautonomia in Patients with Parkinson’s Disease and Hypertension: A Cross-Sectional Pilot Study
Delia TULBA, Aida Cristina Tănăsoiu, A. Constantinescu, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 7, pp. 2225-2225
Open Access
Delia TULBA, Aida Cristina Tănăsoiu, A. Constantinescu, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 7, pp. 2225-2225
Open Access
Tremor and Rigidity in Patients with Parkinson’s Disease: Emphasis on Epidemiology, Pathophysiology and Contributing Factors
Shivam Kumar, Lav Goyal, Shamsher Singh
CNS & Neurological Disorders - Drug Targets (2021) Vol. 21, Iss. 7, pp. 596-609
Closed Access | Times Cited: 27
Shivam Kumar, Lav Goyal, Shamsher Singh
CNS & Neurological Disorders - Drug Targets (2021) Vol. 21, Iss. 7, pp. 596-609
Closed Access | Times Cited: 27
Several neuropeptides involved in parkinsonian neuroprotection modulate the firing properties of nigral dopaminergic neurons
Lei Chen, Cui Liu, Yan Xue, et al.
Neuropeptides (2023) Vol. 99, pp. 102337-102337
Closed Access | Times Cited: 8
Lei Chen, Cui Liu, Yan Xue, et al.
Neuropeptides (2023) Vol. 99, pp. 102337-102337
Closed Access | Times Cited: 8
Targeting sleep and the circadian system as a novel treatment strategy for Parkinson’s disease
Beatrix Feigl, Simon J.G. Lewis, Oliver Rawashdeh
Journal of Neurology (2023) Vol. 271, Iss. 3, pp. 1483-1491
Open Access | Times Cited: 8
Beatrix Feigl, Simon J.G. Lewis, Oliver Rawashdeh
Journal of Neurology (2023) Vol. 271, Iss. 3, pp. 1483-1491
Open Access | Times Cited: 8
Sex-dimorphic functions of orexin in neuropsychiatric disorders
Jinghan Zhang, Kangyu Jin, Bing Chen, et al.
Heliyon (2024) Vol. 10, Iss. 16, pp. e36402-e36402
Open Access | Times Cited: 2
Jinghan Zhang, Kangyu Jin, Bing Chen, et al.
Heliyon (2024) Vol. 10, Iss. 16, pp. e36402-e36402
Open Access | Times Cited: 2
Pharmacological interventions targeting α-synuclein aggregation triggered REM sleep behavior disorder and early development of Parkinson's disease
Lida Du, Xiaoli He, Xiaonuo Fan, et al.
Pharmacology & Therapeutics (2023) Vol. 249, pp. 108498-108498
Closed Access | Times Cited: 6
Lida Du, Xiaoli He, Xiaonuo Fan, et al.
Pharmacology & Therapeutics (2023) Vol. 249, pp. 108498-108498
Closed Access | Times Cited: 6
Exploring the Role of Orexinergic Neurons in Parkinson’s Disease
Sachin Kumar, Tapan Behl, Aayush Sehgal, et al.
Neurotoxicity Research (2021) Vol. 39, Iss. 6, pp. 2141-2153
Closed Access | Times Cited: 12
Sachin Kumar, Tapan Behl, Aayush Sehgal, et al.
Neurotoxicity Research (2021) Vol. 39, Iss. 6, pp. 2141-2153
Closed Access | Times Cited: 12
Sleep duration in middle-aged years of life predicts the age of diagnosis of Parkinson's disease
Cayla Clark, Joshua I. Gold, Brandon R. Rigby
Sleep Medicine X (2024) Vol. 8, pp. 100123-100123
Open Access | Times Cited: 1
Cayla Clark, Joshua I. Gold, Brandon R. Rigby
Sleep Medicine X (2024) Vol. 8, pp. 100123-100123
Open Access | Times Cited: 1
Inactivation of hypocretin receptor-2 signaling in dopaminergic neurons induces hyperarousal and enhanced cognition but impaired inhibitory control
Mojtaba Bandarabadi, Sha Li, Lea Aeschlimann, et al.
Molecular Psychiatry (2023) Vol. 29, Iss. 2, pp. 327-341
Open Access | Times Cited: 4
Mojtaba Bandarabadi, Sha Li, Lea Aeschlimann, et al.
Molecular Psychiatry (2023) Vol. 29, Iss. 2, pp. 327-341
Open Access | Times Cited: 4
Exploring the Role of Orexin-A Neuropeptide in Parkinson's Disease: A Systematic Review and Meta-Analysis
Vinay Suresh, Mainak Bardhan, Shankhaneel Ghosh, et al.
Clinical Neurology and Neurosurgery (2024) Vol. 242, pp. 108320-108320
Closed Access | Times Cited: 1
Vinay Suresh, Mainak Bardhan, Shankhaneel Ghosh, et al.
Clinical Neurology and Neurosurgery (2024) Vol. 242, pp. 108320-108320
Closed Access | Times Cited: 1
Orexin-B exerts excitatory effects on nigral dopaminergic neurons and alleviates motor disorders in MPTP parkinsonian mice
Kang Bian, Cui Liu, Ying Wang, et al.
Neuroscience Letters (2021) Vol. 765, pp. 136291-136291
Closed Access | Times Cited: 8
Kang Bian, Cui Liu, Ying Wang, et al.
Neuroscience Letters (2021) Vol. 765, pp. 136291-136291
Closed Access | Times Cited: 8
High-fat diet and related obesity provoke neurotoxins and alter neuro-biomarkers involved in Parkinson's disease
Nour Batarseh, Yazan Al Thaher
Obesity Medicine (2023) Vol. 41, pp. 100500-100500
Closed Access | Times Cited: 2
Nour Batarseh, Yazan Al Thaher
Obesity Medicine (2023) Vol. 41, pp. 100500-100500
Closed Access | Times Cited: 2
Unveiling Parkinson’s disease through biomarker research: current insights and future prospects
Nazlı Durmaz Çelik, Serkan Özben, Tomris Özben
Critical Reviews in Clinical Laboratory Sciences (2024), pp. 1-17
Closed Access
Nazlı Durmaz Çelik, Serkan Özben, Tomris Özben
Critical Reviews in Clinical Laboratory Sciences (2024), pp. 1-17
Closed Access
Inactivation of hypocretin receptor-2 signaling in dopaminergic neurons induces hyperarousal and enhanced cognition but impaired inhibitory control
Mojtaba Bandarabadi, Sha Li, Lea Aeschlimann, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Mojtaba Bandarabadi, Sha Li, Lea Aeschlimann, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 1
Orexin action on the dopaminergic system modulates theta during REM sleep and wakefulness
Mojtaba Bandarabadi, Sha Li, Mehdi Tafti, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Mojtaba Bandarabadi, Sha Li, Mehdi Tafti, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
A Bitter Experience That Enlightens the Future: COVID-19 Neurological Affection and Perspectives on the Orexigenic System
Sherine Abdelmissih
Cureus (2022)
Open Access | Times Cited: 1
Sherine Abdelmissih
Cureus (2022)
Open Access | Times Cited: 1
Discovery of New Transmitter Systems and Hence New Drug Targets
Tiffany Schwasinger‐Schmidt, Sheldon Preskorn
Advances in neurobiology (2023), pp. 181-193
Closed Access
Tiffany Schwasinger‐Schmidt, Sheldon Preskorn
Advances in neurobiology (2023), pp. 181-193
Closed Access
